Barcelona, Spain

Lluis Miquel Pages Santacana

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2004-2016

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Lluis Miquel Pages Santacana: Innovator in Pharmaceutical Chemistry

Introduction

Lluis Miquel Pages Santacana is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel therapeutic compounds. With a total of six patents to his name, his work focuses on innovative solutions for medical treatments.

Latest Patents

Among his latest patents, Pages Santacana has developed pyrrolotriazinone derivatives as PI3K inhibitors. These new derivatives possess a specific chemical structure and are accompanied by processes for their preparation, pharmaceutical compositions, and therapeutic applications targeting Phosphoinositide 3-Kinases (PI3Ks). Additionally, he has introduced substituted pyrazolo[1,5-a]pyridines as JAK inhibitors. This patent also includes the chemical structure, preparation processes, and therapeutic uses aimed at inhibiting Janus Kinases (JAK).

Career Highlights

Throughout his career, Pages Santacana has worked with notable companies such as Almirall, S.A. and Almirall Prodesfarma, S.A. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovation and contribute to the development of effective therapies.

Collaborations

He has collaborated with esteemed colleagues, including Joan Taltavull Moll and Silvia Fonquerna Pou. These partnerships have further enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Lluis Miquel Pages Santacana stands out as a key figure in pharmaceutical innovation, with a focus on developing new therapeutic agents. His contributions through patents and collaborations continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…